We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12B
AUM Growth
-$622M
Cap. Flow
-$298M
Cap. Flow %
-2.48%
Top 10 Hldgs %
21.36%
Holding
837
New
28
Increased
81
Reduced
101
Closed
16

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$5.83K
2
RY icon
Royal Bank of Canada
RY
+$4.09K
3
RIO icon
Rio Tinto
RIO
+$3.61K
4
AMGN icon
Amgen
AMGN
+$3.58K
5
ARW icon
Arrow Electronics
ARW
+$3.22K

Top Sells

Rank Stock Value
1
EDU icon
New Oriental
EDU
+$35.3M
2
TIF
Tiffany & Co.
TIF
+$27.7M
3
VRNS icon
Varonis Systems
VRNS
+$17.6M
4
OSB
Norbord Inc.
OSB
+$16.7M
5
QEP
QEP RESOURCES, INC.
QEP
+$13.7M

Sector Composition

Rank Sector Weight
1 Healthcare 34.23%
2 Technology 22.73%
3 Consumer Discretionary 9.47%
4 Financials 7.93%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDGL icon
426
Madrigal Pharmaceuticals
MDGL
$12.6B
$3.39M 0.03%
31,722
– –
YUM icon
427
Yum! Brands
YUM
$41.9B
$3.35M 0.03%
32,166
– –
YUMC icon
428
Yum China
YUMC
$15.7B
$3.31M 0.03%
60,382
– –
GPN icon
429
Global Payments
GPN
$24.1B
$3.31M 0.03%
15,979
– –
AFL icon
430
Aflac
AFL
$65.5B
$3.3M 0.03%
77,261
+28
+0% +$1.34K
BRKR icon
431
Bruker
BRKR
$9.4B
$3.29M 0.03%
63,199
– –
SNY icon
432
Sanofi
SNY
$107B
$3.27M 0.03%
70,048
-66
-0.1% -$3.17K
COP icon
433
ConocoPhillips
COP
$144B
$3.26M 0.03%
84,854
– –
MLM icon
434
Martin Marietta Materials
MLM
$34.2B
$3.25M 0.03%
11,931
– –
HBAN icon
435
Huntington Bancshares
HBAN
$34B
$3.24M 0.03%
266,831
– –
PHM icon
436
Pultegroup
PHM
$25.2B
$3.19M 0.03%
76,899
– –
VRAY
437
DELISTED
ViewRay, Inc.
VRAY
$3.16M 0.03%
860,962
+9
+0% +$44
ADVM
438
DELISTED
Adverum Biotechnologies
ADVM
$3.11M 0.03%
29,849
– –
SWK icon
439
Stanley Black & Decker
SWK
$14.5B
$3.11M 0.03%
18,109
– –
OXY icon
440
Occidental Petroleum
OXY
$55.7B
$3.08M 0.03%
185,084
– –
IDXX icon
441
Idexx Laboratories
IDXX
$44.9B
$3.04M 0.03%
6,334
– –
MRVL icon
442
Marvell Technology
MRVL
$147B
$3.02M 0.03%
66,262
– –
ZM icon
443
Zoom
ZM
$27.1B
$3.02M 0.03%
9,328
– –
GMAB icon
444
Genmab
GMAB
$17.5B
$2.98M 0.02%
76,449
+67
+0.1% +$2.52K
BSX icon
445
Boston Scientific
BSX
$68.4B
$2.98M 0.02%
86,333
– –
AAL icon
446
American Airlines Group
AAL
$9.82B
$2.94M 0.02%
194,139
– –
KZR
447
DELISTED
Kezar Life Sciences
KZR
$2.93M 0.02%
58,496
– –
FSLR icon
448
First Solar
FSLR
$21.4B
$2.89M 0.02%
30,405
– –
OMC icon
449
Omnicom Group
OMC
$22.7B
$2.88M 0.02%
48,106
– –
REGI
450
DELISTED
Renewable Energy Group, Inc.
REGI
$2.88M 0.02%
42,316
– –
16 17
18
19 20

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2021 Portfolio in Review

As of Q1 2021, Candriam SCA held 837 positions worth $12B, down 4.9% from $12.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q1 2021 filing shows 28 new, 81 increased, 101 reduced and 16 closed positions. Its largest new stake was Arrow Electronics: 31 shares worth $3K. The largest sale was New Oriental, an estimated $35.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Candriam SCA's largest Q1 2021 buy was Arrow Electronics: 31 shares worth $3K.
  • Candriam SCA added most to AstraZeneca in Q1 2021, an estimated $5.83K increase.
  • Candriam SCA's biggest Q1 2021 reduction was New Oriental, cutting an estimated $35.3M.
  • Candriam SCA fully exited Tiffany & Co. in Q1 2021, selling an estimated $27.7M.
  • Candriam SCA's ten largest holdings make up 21% of its $12B portfolio in Q1 2021.
  • Candriam SCA opened 28 new positions and closed 16 in Q1 2021.
  • Candriam SCA's portfolio value fell 4.9% quarter-over-quarter to $12B.

Based on Candriam SCA's 13F filing for Q1 2021, filed 29 Apr 2021.